Semaglutide Biosimilar
$175.00 – $700.00
Semaglutide Biosimilar. Semaglutide biosimilar stable cell line is available for licensing to manufacture the semaglutide biosimilar. The research grade semaglutide biosimilar is for research use only (RUO).
- Product Details
- Description
- Additional information
- More Offers
| Catalog No. | C074P |
|---|---|
| Product Name | Semaglutide Biosimilar |
| Supplier Name | Syd Labs, Inc. |
| Brand Name | Syd Labs |
| Synonyms | Acylated Glucagon-like Peptide-1 Receptor Agonist, Human GLP-1 Receptor Agonist, Human GLP-1 Analog |
| Source/Host | The recombinant peptide semaglutide biosimilar was produced in the semaglutide stable cell line. |
| Endotoxin | < 1 EU per 1 mg of the peptide by the LAL method. |
| Purity | >95% by SDS-PAGE under reducing conditions and HPLC. |
| Shipping | The research grade semaglutide biosimilar is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied. |
| Note | Semaglutide biosimilar stable cell line is available for licensing to manufacture the semaglutide biosimilar. The research grade semaglutide biosimilar is for research use only (RUO). |
| Order Offline | Phone: 1-617-401-8149 Fax: 1-617-606-5022 Email: message@sydlabs.com Orleave a message with a formal purchase order (PO) Or credit card. |
Description
C074P: Semaglutide Biosimilar
Background
What is research grade semaglutide biosimilar? Research grade semaglutide biosimilar has the same amino acid sequence as semaglutide, a recombinant peptide which presents 94% sequence homology to the human glucagon-like peptide-1 (GLP-1), differing primarily by two amino-acid substitutions at positions 8 and 34, where alanine and lysine are replaced by 2-aminoisobutyric acid and arginine, respectively. Liraglutide is made by attaching a C-18 fatty acid (stearic diacid) with a glutamic acid spacer on the remaining lysine residue at position 26 of the peptide precursor. Semaglutide is resistant to the dipeptidylpeptidase-4 enzyme whic degrades the natural hormone. As a GLP-1 receptor agonist, Semaglutide mimics the action of the human incretin glucagon-like peptide-1 (GLP-1), thereby increasing insulin secretion and increasing blood sugar disposal and improving glycemic control. Semaglutide is an anti-diabetic medication used to treat type 2 diabetes, obesity, and chronic weight management.
Syd Labs also provides the following GLP-1 receptor agonist biosimilar peptide:
Liraglutide biosimilar
Please remember our product information: Semaglutide Biosimilar: C074P Syd Labs
Additional information
| Ship from Country | USA |
|---|---|
| Size | 180 mg, 60 mg, 20 mg |
